if my job is anything, it's to anticipate and make efficient. that's what cannabis does. balances the yen to our yang. the karmic effect.
you just don't see people with a bud tender ad vitals meters to c what balances them with a toke. because it's about money... not your life.
i watched as different cultivars did different things in her body and learned how to apply them to walk all over centuries of medical "science"; with a LITTLE FUCKING COMPASSION, rather than a deposit slip.
they're harming us, but not listing to our bodies. everything her doc gave her, jacked her vitals... everything i gave her, balanced and maintained.. side effect, free. migraine... done... pain... done... vitals... done... doctors: pieces of excrement... if they're not doing this.
her peeps have had years to do the damage and i regulated her i a day. cocksuckers. how much u make in those years. pffft...
overinflating and underinflating the circulatory system, over 2 billion times a lifetime... why would we not anticipate and regulate, since birth; as one doesn't have to be high, to do so: because it pays well.
how many doctors verify for themselves to the point of death. to the point of life. to the point of ... if you never reach stroke territory... if you never have to have the headache, or the pain... the stress... if we could go through life, as a perfect, flatline, so to speak, internally; how much longer, could we live? what's a life worth? who's on the hook for my lovely balloon? we know who did it... zero fingerprints; zero care to the future. 22bil... let's do the math. they kill 50k, annually... been slingin a century... assuming they wouldn't stop til told and didn't mind the graveyard views.... that's less than 5k, per death and many are attributed to other things. wonder how many dollars they profited over a year. let's take a look; shalllll weee?
Under the agreement, the companies would pay a total of $22 billion in cash ...
Quantity Quantities of analgesic opioids, as measured in morphine milligram equivalents (MMEs) sold from manufacturers to retail pharmacies gradually increased from nearly 50 billion MME in 1992 to about 73 billion MME in 1998, increased more steadily in 1999 – 2000 to 92 billion MME, and then rapidly increased by an average rate of more than 15 billion MMEs per year for the next decade, peaking at nearly 250 billion MME of opioids sold in 2010 (figure 1). Over the entire timeframe, generic versions of opioids were available for many of the opioid products on the market, and comprised most of the MMEs sold to pharmacies over the entire timeframe studied. The generic share of MMEs has steadily increased in the most recent timeframe with generics comprising 53% of MMEs sold in 2000, and rising
funny, how that works. bullshit's gettin thicker.